Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer
暂无分享,去创建一个
P. Gibbs | J. Tie | M. IJzerman | R. Wong | S. Kosmider | Margaret Lee | A. Jalali | K. Degeling | V. Wong | G. Gard | C. Dunn | Y. To